HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $202,000 | -70.0% | 24,296 | -80.3% | 0.00% | -100.0% |
| Q1 2021 | $673,000 | +27.2% | 123,240 | 0.0% | 0.00% | – |
| Q4 2020 | $529,000 | +42.6% | 123,240 | 0.0% | 0.00% | – |
| Q3 2020 | $371,000 | -2.9% | 123,240 | 0.0% | 0.00% | – |
| Q2 2020 | $382,000 | +40.4% | 123,240 | 0.0% | 0.00% | – |
| Q1 2020 | $272,000 | -36.0% | 123,240 | -11.5% | 0.00% | – |
| Q4 2019 | $425,000 | -0.7% | 139,202 | 0.0% | 0.00% | – |
| Q3 2019 | $428,000 | +54.0% | 139,202 | 0.0% | 0.00% | – |
| Q2 2019 | $278,000 | -53.7% | 139,202 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $600,000 | +35.4% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $443,000 | -39.4% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $731,000 | -1.9% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $745,000 | +7.0% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $696,000 | +51.6% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $459,000 | -12.1% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $522,000 | +47.0% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $355,000 | -1.9% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $362,000 | -14.8% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $425,000 | +12.1% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $379,000 | -4.8% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $398,000 | -5.2% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $420,000 | -13.0% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $483,000 | -8.2% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $526,000 | -33.7% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $793,000 | +9.4% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $725,000 | 0.0% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $725,000 | +27.4% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $569,000 | -10.1% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $633,000 | +2.1% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $620,000 | -11.4% | 139,202 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $700,000 | -5.0% | 139,202 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $737,000 | +11.2% | 140,202 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $663,000 | – | 140,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |